As the readmissions penalty bump to 2 percent is on the October horizon, Indiana’s ACOs and hospitals will soon be able to use predictive software to assist them in lowering those rates and determining what’s causing them in the first place – maybe as early as the end of Q3.
The Indiana Health Information Exchange (IHIE) and Predixion Software have announced a partnership to that will use IHIE’s large information network and Predixion’s predictive analytics capabilities to help ACOs and hospitals act on data throughout the Hoosier state. The first problem they’ll tackle is assessing readmission risk stratifications (how likely a particular patient is to be readmitted), with the aim of saving hospitals penalty fees and communicating better with patients who might otherwise end up back at the hospital.
Predixion Readmissions Insight is supposed to be easy-to-use, actionable software, accessible from a tablet or monitor so clinicians can use it as they work with patients.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“What’s exciting about this offering is for a long time we focused on telling you what happened in the past–here’s the trends for diabetes,” Curt Sellke, VP of analytics for IHIE, said. “But what’s exciting about the predictive side is. . . there’s a proactiveness to it. As we’ve talked to our clients and potential clients, that’s really the area they need to go–especially in this era of healthcare reform.”
IHIE maintains the country’s largest inter-organizational clinical data repository, which includes more than 20 terabytes of data and 10 million unique patient records.
Because of this, Sellke said the state is in a unique position to “leverage this very wide and very deep data set” like nowhere else.
Mark McNally, VP of business development at Predixion, said this big data was particularly compelling for Predixion, because it includes diverse geographic and socioeconomic information–from Indianapolis to outer suburbs of Chicago to more rural areas.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
But, he said, not to be confused by the big data; this project isn’t about global models. Each provider will be able to see its own distinct information through Predixion’s software.
Sellke said IHIE selected Predixion for many reasons, among them similar missions, a good dynamic and the confidence IHIE leaders felt when Accenture and GE made large investments in the company.
The Predixion Readmissions Insight program is only the beginning. The partners hope to work on future software to use the same kind of data assessment for projects potentially as big as disease management, pregnancies and even to help employers maintain a healthier workforce.
“The hope that IHIE and Predixion have is to innovate something we can take across the border and potentially share with other parts of the country,” McNally said. “In the early days we’ll be innovating together and then IHIE will move out on its own.”
In an ideal world, Sellke said, after the readmissions module goes live, a new module would roll out every three to six months on a regular basis.
“When you think about healthcare innovation, unfortunately Indiana doesn’t work its way to the top, but we’re going to do this with a lot of things that hopefully help put Indiana on that map,” he said.
